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Abstract 
The presence of several putative Baeyer-Villiger Monooxygenases (BVMOs) encoding genes 
in Aspergillus fumigatus Af293 was demonstrated for the first time. One of the identified 
BVMO-encoding genes was cloned and successfully overexpressed fused to the cofactor 
regenerating enzyme phosphite dehydrogenase (PTDH). The enzyme named BVMOAf1 was 
extensively characterized in terms of its substrate scope and essential kinetic features. It 
showed high chemo-, regio- and stereoselectivity not only in the oxidation of asymmetric 
sulfides, (S)-sulfoxides were obtained with 99% ee, but also in the kinetic resolution of 
bicyclo[3.2.0]hept-2-en-6-one. This kinetic resolution process led to the production of 
(1S,5R) normal lactone and (1R,5S) abnormal lactone with a regioisomeric ratio of 1:1 and 
99% ee each. Besides, different reaction conditions, such as pH, temperature and the presence 
of organic solvents, have been tested, revealing that BVMOAf1 is a relatively robust 
biocatalyst. 
Keywords 
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Introduction 
Baeyer-Villiger monooxygenases (BVMOs) are flavin-dependent enzymes capable of 
catalyzing the insertion of an oxygen atom between a C-C bond in carbonyl compounds 
(Baeyer-Villiger oxidation) such as ketones and aldehydes, yielding esters and lactones 
(Kamerbeek 2003a). These enzymes can also oxidize C = C bonds to epoxides (Colonna 
2002) and heteroatom-containing molecules; e.g. organic sulfides, amines and boron 
compounds (Brondani 2011). Therefore, BVMOs are able to work on either electron-poor or 
electron-rich molecules. Remarkably, different mechanisms have been proposed for these O2-
driven reactions (Ottolina 2005). In the first case, a nucleophilic attack takes place 
resembling the chemical Baeyer-Villiger reaction conducted by peracids. Unlike this, to 
oxidize a heteroatom, an electrophilic attack might take place. A common feature among 
these mechanisms is the strict dependence of a reduced nicotinamide coenzyme (NAD(P)H) 
for the reduction of the flavin cofactor (FAD). In a subsequent step, the reduced flavin reacts 
rapidly with molecular oxygen to form a reactive peroxyflavin intermediate. Only after the 
oxygenation of the substrate, the enzyme reverts to the oxidized state. Subsequently the 
oxidized NAD(P)+ coenzyme is released. This latter process has been shown to be rate-
determining in the kinetic mechanism studied for the BVMOs, cyclohexanone 
monooxygenase (CHMO) (Sheng 2001) and phenylacetone monooxygenase (PAMO) (Torres 
Pazmiño et al. 2009a, 2009b). 
BVMOs are an attractive alternative in organic synthesis due to their relaxed substrate 
acceptance, their high chemo-, regio- and enantioselectivity, as well as their optimal activity 
in mild and environmentally-friendly conditions. Because of this, the last few years have 
witnessed a steady growth in research efforts towards discovery and engineering of BVMOs 
(Leisch 2012, Balke 2012). By random mutagenesis and site directed evolution, it has been 
possible to expand the substrate specificity, as well as to improve and change the 
stereoselectivity of cyclopentanone monooxygenase (CPMO) (Clouthier and Kayser 2006) 
and CHMO (Zhang 2013), among others. Moreover, the designing of chimeric BVMOs by 
using the scaffold of the thermostable PAMO and introducing novel selectivities of other 
BVMOs has been developed. Interestingly, it has been demonstrated that the properties of 
chimeric BVMOs are not directly predictable from the parental enzyme features (van Beek 
2012). Concerning the finding of novel BVMOs, the most striking, recently reported example 
is the large set of rhodococcal BVMOs that has been produced and characterized (Szolkowy 
2009; Riebel 2012). The genome of Rhodococcus jostii was found to contain 22 type I 
BVMOs which were all functionally expressed and their biocatalytic properties assessed. 
This example has revealed that the sequence diversity among this class of flavoprotein 
monooxygenases is extremely broad, even within a single genome. Despite the recent efforts 
in discovery and engineering of novel enzymes, the number of recombinant available 
BVMOs is still rather modest and these are mainly derived from bacterial species. 
Based on the exploration of sequenced genomes, it was proposed that fungal ones are rich in 
BVMO-encoding genes, especially within the Aspergillus genus (Torres and Fraaije 2007). In 
2004, A. parasiticus aflatoxin gene cluster was completely sequenced revealing the presence 
of at least one putative BVMO encoding ORF (Yu 2004a). The biosynthetic pathways for 
aflatoxins B1, G1 and B2, G2, starting from the early precursor nosrolinate anthrone, have 
been fully described (McGuire and Townsend 1993; Yu 2004b). However, not all the 
involved enzymes have been identified at the molecular/biochemical level. Moreover, the 
genome of A. parasiticus has not been completely sequenced, therefore the presence of other 
BVMO genes can not be ruled out. More recently, the cythochalasin gene cluster from A. 
clavatus NRRL 1 has been identified and engineered. It was demonstrated that within the 
multi-domain polyketide synthase-nonribosomal peptide synthetase complex (PKS–NRPS), 
responsible for the cytochalasin E and K synthesis, there might be a BVMO (CcsB) which 
displays a rare reaction on a vinyl carbonate moiety (Qiao 2011). The sequencing of the A. 
fumigatus Af293 genome was reported in 2005 (Nierman 2005). This allergenic pathogen is 
known to be a source of toxic compounds such as helvolic acid and fumagillin, which are 
probably the result of biosynthetic routes that involve BVMOs. Moreover, an early step 
catalyzed by a PKS complex leading to a lactone moiety, was identified in the biosynthesis of 
the meroterpenoid pyripyropene (Itoh 2010). In addition to the genetic and molecular 
evidence of BVMOs occurrence, there are many biotransformation reports where A. 
fumigatus catalyzes Baeyer-Villiger oxidations and enantioselective sulfoxidations (Jones 
1994, Mascotti 2012). These biochemical evidences support the presence of more than one 
BVMO in this species. So far, only one fungal BVMO has been produced as a recombinant 
enzyme: cycloalkanone monooxygenase (CAMO) from the ascomycete Cylindrocarpon 
radicicola (Leipold et al. 2011). All other available recombinant BVMOs belong to 
prokaryotic genomes. 
Herein we describe the identification of a set of BVMOs from Aspergillus fumigatus Af293. 
In particular, we have cloned, expressed and biochemically characterized BVMOAf1, being 
the first Aspergillus-derived BVMO to be reported. 
Materials and methods 
Chemicals 
All the reagents and chemicals were obtained from Across Organics and Sigma-Aldrich. 
Enzymes and oligonucleotides were purchased from Invitrogen, Sigma, NEB and 
Biodynamics. In-fusionTM 2.0 and ChampionTM pET200 Directional TOPO® expression kits 
were purchased from Clonetech and Invitrogen, respectively. 
Data mining and searching for Aspergillus fumigatus BVMOs 
The NCBI server was used for protein and DNA sequence retrieval by using BLASTP and 
TBLASTN under default parameters (http://blast.ncbi.nlm.nih.gov/Blast.cgi). By using 
PAMO and CHMO sequences (Bonsor 2006), A. fumigatus Af293 genomic, ESTs and 
protein databases were investigated for the presence of BVMO genes. The identified BVMO 
sequences were combined with the known bacterial BVMOs sequences and analyzed using 
CLUSTALW multiple alignment software (http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
Further sequence analysis based on consensus motifs was made. Based on these sequence 
analyses, putative BVMO-encoding genes were identified. 
Cloning and gene expression 
Genomic DNA from A. fumigatus Af293 (obtained from the FGSC) was purified as described 
before (Dellaporta 1983). The three selected BVMO-encoding genes; Af1 (XM_742067), Af2 
(XM_741856) and Af3 (XM_750181) were amplified by PCR using a proofreading 
polymerase (Phusion DNA polymerase, NEB). Full length PCR products were cloned into the 
pET200/D TOPO vector. Based on the sequence alignment and domain analyses, a truncated 
form of Af1 (1614 bp), full length Af2 and a truncated form of Af3 (1632 bp) were also cloned 
into a pCRE2 vector by using the In-Fusion PCR Cloning kit (Clontech) (see online resource 
for details). This vector harbors a codon-optimized gene encoding a mutant of phosphite 
dehydrogenase (PTDH) with an N-terminal His-tag (Torres Pazmiño 2009b). For expression 
experiments, BL21(DE3) and TOP10 bacterial strains were transformed with pET200 and 
pCRE-based constructs, respectively. For expression optimization of pET200 constructs, 
cultures were grown at 37°C up to an OD600 of 0.5. IPTG was added at different final 
concentrations (1.0 and 0.5 mM) and cultures were grown for 6 h at four different 
temperatures (17, 24, 30 and 37°C). For TOP10 cells harboring pCRE2 constructs, expression 
was assessed using 24 deep square-well micro-titer plates with the sandwich cover system, 
shaking at 200 rpm. Cells were grown in the presence of different L-arabinose concentrations 
(0.002%, 0.02%, 0.2% w/v) at four different temperatures (17°C for 48 h, 24°C for 36 h, 
30°C for 24 h and 37°C for 12 h). In both cases, cell extracts were obtained using 
DNase/lysozyme. Total extracts as well as clarified extracts were analyzed by SDS-PAGE 
upon blue staining (SimplyBlueTM SafeStain, Invitrogen) for detecting soluble expression of 
the enzyme. 
Purification of recombinant BVMOAf1 
The His-tagged PTDH-BVMOAf1 was purified using the following procedure: TOP10 cells 
harboring the pCRE-Af1 construct, from 500 mL culture (36 h, 24°C, 0.02% w/v arabinose) 
were harvested by centrifugation. Cells were resuspended in 20 mL of 50 mM Tris/HCl pH 
8.0 buffer containing 150 mM KCl, 10% (v/v) glycerol, 0.5 mM DTT, 0.5 mM PMSF and 
100 µM FAD. Cells were disrupted by sonication and subsequently centrifuged (15,000 g for 
45 min at 4°C, JA-17 rotor, Beckman Coulter). Clarified cell extract was loaded on 2 mL of 
Ni2+ Sepharose HP (GE Healthcare) and incubated for 1 h at 4°C while gently mixing. Then, 
the column was washed with three column volumes of 50 mM Tris/HCl pH 8.0, followed by 
three column volumes of same buffer containing 5.0 mM imidazole. The protein was eluted 
in the same buffer containing 500 mM imidazole. To remove imidazole, yellow fractions 
containing FAD-bound protein were applied on an Econo-Pac 10DG desalting column (Bio-
Rad) pre-equilibrated with buffer Tris/HCl pH 8.0. The desalted and aliquoted protein was 
stored at −80°C. 
The integrity and purity of protein samples was evaluated by SDS-PAGE. To quantify the 
purified enzyme, the extinction coefficient of FAD bound to PTDH-BVMOAf1 was 
determined as described previously (Fraaije 2005). UV–Vis absorption spectra were collected 
on a Perkin-Elmer Lambda Bio40 spectrophotometer. 
Biocatalytic characterization 
Substrate screening was made according to the protocol described by Riebel (2012). All 
substrates were tested at 2.5 mM. To analyze the enantioselectivity of PTDH-BVMOAf1, 
enzyme-mediated oxidations were performed using rac-bicyclo[3.2.0]hept-2-en-6-one and 
thioanisole as substrates. Reaction mixtures (1 mL) containing 50 mM Tris/HCl pH 8.0, 2.5 
mM substrate, 50 µM NADPH, 10 mM phosphite and 1.0 µM enzyme were incubated for 4 h 
and/or 24 h at 25°C, 200 rpm. In the case of rac-bicyclo[3.2.0]hept-2-en-6-one, samples were 
taken at regular time-intervals. Reactions were quenched by addition of 1 mL ethyl acetate. 
The organic layer was dried over MgSO4 and subsequently analyzed by GC-FID as 
previously described (Kamerbeek 2003b). 
Enzyme activity 
Enzyme activity was measured spectrophotometrically by monitoring the substrate-dependent 
decrease in NADPH at 340 nm (ε340 = 6.22 mM-1 cm-1). Reaction mixtures typically 
contained 50 mM Tris/HCl pH 8.0, 100 µM NADPH, 2.0 mM rac-bicyclo[3.2.0]hept-2-en-6-
one and 0.05 to 0.35 µM of enzyme. All kinetic measurements were performed at 25°C using 
air-saturated buffers. To determine the coenzyme specificity, NAD(P)H concentrations 
ranging from 0.05 to 2.0 mM were tested. The observed rate constants were fitted with the 
Michaelis-Menten equation using SigmaPlot for Windows version 10.0. 
Activity and thermal stability were measured spectrophotometrically by performing the 
reaction at different temperatures, ranging from 20 to 55°C. The melting point was 
determined by the previously described method Thermo-FAD (Forneris 2009). Activity and 
stability over pH were measured by performing the reaction at different pHs. The Britton & 
Robinson buffer (Thomas 1931, Baldrian 2004) at a concentration of 50 mM was used in the 
pH range of 4.0-10.0. 
The activity in the presence of 5% (v/v) of ethanol, methanol, t-butanol, dioxane and DMSO 
was tested. To check the enzyme stability, enzyme was pre-incubated for 1 h at room 
temperature in the presence of 5% (v/v) of the selected solvents, and remaining activity was 
measured spectrophotometrically. The same protocol was followed to test activity in other 
conditions such as the presence of salts, glycerol and different buffer types. 
Results 
Mining the A. fumigatus Af293 genome for BVMO-encoding genes 
By using the sequences of previously reported BVMOs (PAMO & CHMO) as probes, 13 
predicted proteins from A. fumigatus with significant similarity (E-value < 1.10-6) were 
retrieved by BLASTP. No additional sequences were retrieved by TBLASTN on genomic 
and mRNA databases. The retrieved protein sequences were curated by confirming the 
presence of BVMO-typifying sequence hallmarks, namely two Rossmann folds GxGxx(G/A) 
flanking the FxGxxxHxxxW(P/D) motif (Fraaije 2002). Single amino acid substitutions were 
allowed in the latter motif (F/Y or H/Q). Nine predicted genes/proteins fulfilling these 
requirements were selected as putative BVMOs, XM_742067 (protein id XP_747160), 
XM_741856 (protein id XP_746949), XM_750181 (protein id XP_755274), XM_750991 
(protein id XP_75684), XM_749026 (protein id XP_754119), XM_746162 (protein id 
XP_751255), XM_742681 (protein id XP_747774), XM_747111 (protein id XP_75224), 
XM_746209 (protein id XP_75132). These nine ORFs were aligned to genomic sequences to 
detect the presence of introns. Based on this, the three intronless nucleotide sequences 
XM_742067 (protein id XP_747160), XM_741856 (protein id XP_746949) and XM_750181 
(protein id XP_755274) named Af1, Af2 and Af3 respectively, were chosen to be cloned and 
expressed (Figure 1). The enzymes encoded by the selected genes were named BVMOAf1, 
BVMOAf2, and BVMOAf3, according to their source strain, A. fumigatus. 
Figure 1 Multiple sequence alignment of some BVMOs sequences. Sequences are: 
BVMOAf1 (XP_747160), BVMOAf2 (XP_746949) and BVMOAf3 (XP_755274) from A. 
fumigatus Af293, PAMO (YP_289549) from Thermobifida fusca, CHMO (AAG10021) from 
Acinetobacter sp., HAPMO (AAK54073) from Pseudomonas fluorescens, CPDMO 
(BAE93346) from Pseudomonas sp. HI70 and CAMO (AET80001.1) from Cylindrocarpon 
radicicola. The two Rossmann folds (GxGxxG) and the BVMO fingerprint 
(FxGxxxHxxxWP/D) are highlighted. 
The predicted BVMOAf1 contains 905 amino acids comprising an N-terminal BVMO domain 
(~540 residues) fused to a ~360 amino acids long putative polynucleotide synthase domain. 
For this reason, a truncated version of BVMOAf1 (1614 bp) was obtained by deleting 367 C-
terminal residues. The two Rossmann fold motifs are conserved and confirm that the protein 
binds FAD and NADPH. Besides, in the BVMO fingerprint motif the conserved His residue 
is replaced by Gln. 
BVMOAf2 is predicted to be a single, 486 amino acids-long, BVMO-domain. The full length 
encoding gene (1461 bp) was cloned in expression vectors. The BVMO fingerprint as well as 
the two Rossmann fold motifs are fully conserved in this protein. 
The BVMOAf3 amino acid sequence presents an N-terminal extension of 58 residues 
compared to other BVMOs. In this case, a truncated fragment of 1632 bp was subcloned, in 
which the N-terminal extension was removed in order to prevent incorrect folding of the 
recombinant protein. This truncated enzyme comprised 543 amino acids and has canonical 
BVMO fingerprint and Rossmann fold motifs. 
Cloning and expression of recombinant A. fumigatus BVMOs 
Two approaches were assessed. First, the three selected full-length sequences were cloned as 
6xHis fusion into a pET vector under the control of a T7 promoter. Small-scale expression 
conditions were tested for all these constructs. The pET-Af1 and pET-Af3 constructs yielded 
no soluble protein expression, as detected by SDS-PAGE. The pET-Af2 construct allowed us 
to obtain soluble protein, although at a low expression level. In addition, the expressed 
BVMOAf2 did not show affinity towards the Ni2+ resin, preventing affinity chromatography 
purification. However, activity assays using crude extracts of E. coli cells expressing 
BVMOAf2 revealed that this enzyme is active (data not shown). In the case of the Af1 gene, 
we hypothesize that the large C-terminal domain could be responsible for protein 
aggregation. Therefore, we tested the expression and solubility of the cloned BVMOs 
domains fused to an N-terminal His-tagged, cofactor regenerating protein; PTDH. Expression 
tests of these constructs revealed no detectable expression of BVMOAf2 or BVMOAf3, 
whereas BVMOAf1 yielded high expression of a soluble protein of the expected molecular 
weight. This result proves that fusion proteins may have a beneficial influence in the 
expression of non-soluble proteins, such it was the case of BVMOAf1, a fact that has been also 
reported for other BVMOs (Thapa 2008). Therefore, larger scale expression and purification 
were performed for this PTDH-BVMO fusion protein. 
In the case of pCRE2-Af2 construct the lack of expression may be due to the deletion of the 
N-terminal tail. For the gene Af3, functional expression was not achieved in any of the tested 
conditions indicating that a different expression system may be suitable in this case. 
Purification and spectral characterization of PTDH-BVMOAf1 
From a 2 L culture, 33 mg of His-tagged protein could be purified. The protein migrated as a 
single band on SDS-PAGE, corresponding to a mass of 100 kDa. This is in good agreement 
with the calculated mass for the PTDH-BVMOAf1 fusion protein (35 + 60.5 kDa). The yellow 
purified protein displayed two absorption maxima at 380 nm and 449 nm, as it is expected for 
a flavoprotein. The estimated extinction coefficient for the purified enzyme was determined 
as ε449 = 13.3 mM-1 cm-1. The addition of NADPH resulted in a complete reduction of the 
flavin evidenced by the spectral analysis, strongly suggesting that the recombinant protein is 
functional (Figure 2). The ratio of A280/A449 was found to be 14, indicating that the protein is 
mainly in its holo form. 
Figure 2 Spectral characterization of BVMOAf1.Visible spectra of native BVMOAf1 (solid 
line) and BVMOAf1 after unfolding by 1% SDS and incubation at 80°C (dotted line), and 
spectral changes observed upon reduction of BVMOAf1 by excess of NADPH (dashed line). 
Catalytic properties 
In order to evaluate the biocatalytic potential of the recombinant enzyme, a set of 46 possible 
substrates was tested, including linear, cyclic, bicyclic and aromatic ketones, steroids, 
aromatic prochiral sulfides, diketones and bifunctional molecules. The assay revealed that 
four compounds namely rac-bicyclo[3.2.0]hept-2-en-6-one, benzyl ethyl sulfide, thioanisole 
and 3-phenylpentane-2,5-dione triggered significant NADPH consumption, which was 
evidenced by the phosphate production (Additional file 1 Table S2). In order to confirm the 
enzyme BVMO activity and to assess its enantioselectivity, reactions were carried out using 
the model substrate rac-bicyclo[3.2.0]hept-2-en-6-one since both enantioselectivity and 
regioselectivity, are simultaneously tested (Mihovilovic 2005). In this reaction a kinetic 
resolution process takes place, the migration of the more-substituted carbon atom generates 
the “normal” lactone, while the migration of the less-substituted carbon atom forms the 
“abnormal” lactone (Renz and Meunier 1999). It was observed that BVMOAf1 converted the 
substrate in a highly selective fashion, successfully achieving the kinetic resolution of the 
substrate. The normal lactone (1S,5R)-2-oxabicyclo[3.3.0]oct-6-en-3-one (ee > 99%) was 
generated in a fast reaction, and full conversion was reached after 45 min. In contrast, the 
abnormal lactone (1R,5S)-3-oxabicyclo[3.3.0]oct-6-en-2-one (ee > 99%) was the product of a 
slow reaction and full conversion was achieved at 4 h (Figure 3). The ratio of the 
regioisomeric products was 1:1, with excellent optical purities of the formed lactones. 
Figure 3 Oxidation of rac-bicyclo[3.2.0]hept-2-en-6-one catalyzed by BVMOAf1.(A) Time 
course BVMOAf1-catalyzed oxidation of rac-bicyclo[3.2.0]hept-2-en-6-one (1) to 2-
oxabicyclo[3.3.0]oct-6-en-3-one (2) and 3-oxabicyclo[3.3.0]oct-6-en-2-one (3). (B) 
Structural formulas of bicyclo [3.2.0]hept-2-en-6-one isomers and lactones formed by 
BVMOAf1 activity. 
When thioanisole was tested as prochiral substrate, 88% conversion was achieved after 2 h. 
The (S)-sulfoxide was obtained with excellent enantioselectivity (ee > 99%). A similar 
optical purity was observed when the substrate was benzyl ethyl sulfide (Table 1). In both 
cases, sulfone formation was detected. In case of thioanisole, a small amount was produced 
after 2 h of conversion. On the other hand, in the case of benzyl ethyl sulfide the amount of 
sulfone was higher at shorter reaction times. 
Table 1 Conversion of sulfides by BVMOAf1 
Substrate Time (min)a Sulfoxide (%) Sulfone (%) ee (%) 
 180 88 8 >99 (S) 
 60 56 37 >99 (S) 
180 25 75 >99 (S) 
a
 Reactions were monitored by sampling at regular time intervals. Full substrate conversion 
was observed at 180 min in both cases. For GC conditions, see online resource. 
Steady-state kinetic measurements 
Steady-state kinetic parameters were determined for three of the substrates (Table 2). 
NADPH was found to be very well recognized by BVMOAf1 (KM value < 5 µM). No 
significant activity was detected with NADH concentrations up to 1.0 mM, showing that this 
enzyme only accepts NADPH as hydride donor. BVMOAf1 highest apparent affinity was 
towards benzyl ethyl sulfide (KM = 23.5 µM). The maximal rate of catalysis was in the same 
range for all the tested substrates, kcat ≈ 0.5 s-1. This suggests that the conversion rates are 
independent of the type of substrate and hints to a rate-limiting step that does not involve the 
oxygenation reaction. Further kinetics analyses will reveal the rate limiting step during 
catalytic cycle. 
Table 2 Steady-state kinetic parameters of BVMOAf1 
Substrate KM (µM) kcat (s-1) kcat/KM (s-1/mM-1 
 23.5 ± 0.1 0.47 ± 0.04 20 
 118.8 ± 0.1 0.46 ± 0.02 4.1 
 179.8 ± 0.1 0.36 ± 0.06 2.0 
Optimal conditions for activity & stability 
Optimal temperature was determined toward rac-bicyclo[3.2.0]hept-2-en-6-one. It was found 
that the enzyme exhibits its highest activity at 50°C (Figure 4-A). Based on this observation, 
the remaining activity was measured after 1.5 h of pre-incubation at different temperatures 
(20, 30, 35, 40, 50 and 60°C) and no significant loss of activity was detected up to 35°C 
(Figure 4-B). The melting temperature (Tm) was 41.1°C and 43.3°C in Tris/HCl and 
phosphate buffers, respectively. The difference between both values could be attributed to the 
ionic nature of phosphate buffer, which may change the unfolding temperature, as it has been 
previously described for other enzymes (Cacace 1997). Alternatively, the inorganic 
phosphate may occupy binding pockets that are normally occupied by the phosphate moieties 
of NADP+ during catalysis, thereby stabilizing the enzyme. 
Figure 4 Optimal conditions for activity. (A) temperature-dependent activity profile, (B) 
temperature-dependent stability, for which the remaining activity was measured after 1.5 h 
incubation at the indicated temperatures, (C) pH-dependent activity profile, and (D) pH-
dependent stability profile, by measuring the activity after 1 h incubation at different pH 
values. The error bars indicate standard deviations. 
The optimum pH for activity was determined to be 8.0, a typical value for Type I BVMOs 
(Figure 4-C). The effect of protein pre-incubation during 1 h at different pH values was also 
evaluated. Notably, the enzyme remained active at pHs ranged from 6.0 to 10.0 (Figure 4-D). 
Different buffers were tested but no significant changes were observed among them. 
The addition of organic solvents to enzyme-catalyzed procedures is usually used to improve 
the solubility of the substrate/product and/or to increase the reaction yield. Therefore, the 
activity of BVMOAf1 in the presence of ethanol, methanol, t-butanol, dioxane and DMSO 
(5% v/v) was evaluated. None of the solvents significantly influenced the enzyme activity. 
Based on this, enzyme stability towards these solvents was tested. Remarkably, the enzyme 
remained fully active after 1 h of pre-incubation with all the solvents, showing a very good 
tolerance to harsh reaction conditions (Figure 5). 
Figure 5 BVMOAf1 stability in organic solvents. Activity was measured after 1.0 h 
incubation in the presence of 5% (v/v) of organic solvents at room temperature. As control, 
no solvent was added to the buffer. The error bars indicate standard deviations. 
Discussion 
In this study we have identified nine nucleotide sequences in the genome of A. fumigatus 
Af293 that contain all sequence hallmarks that, at the protein sequence level, are typical for 
Type I BVMOs. Interestingly, sequence identity among these predicted enzymes is rather low 
(ranging from 15% to 40%). Therefore, this fungus is a very interesting model to understand 
the genetic and molecular basis of the diversity of these enzymes within eukaryotic genomes, 
such as Rhodococcus is a model for prokaryotes (Balke 2012). Besides, from a biocatalytic 
point of view, this fact could explain the whole-cell activity of A. fumigatus toward a broad 
range of substrates (Bastos Borges 2009). Moreover, the poor stereoselectivity evidenced in 
some cases could be explained to the occurrence of different BVMOs with opposite 
selectivities (Mascotti 2012). To explore the biocatalytic potential of these fungal BVMOs, 
we have cloned three of these genes and succeeded in the effective expression of one of the 
targeted BVMOs, BVMOAf1. A thoroughly characterization of this first recombinant 
Aspergillus BVMO has been performed. 
The BVMOAf1 primary sequence shows 37% identity with the only eukaryotic BVMO 
previously described, CAMO (Leipold 2012). It displays a higher degree of homology with 
bacterial BVMOs (40% for CHMO from Acinetobacter and 42% for PAMO from 
Thermobifida fusca). Interestingly, BVMOAf1 has an amino acid substitution (H173Q) in the 
consensus BVMO motif. This residue has been proposed to be involved in conformational 
changes during the catalytic cycle, acting as a linker between the FAD and NADPH binding 
sites (Malito 2004). The mutation of the central His residue in other BVMOs has dramatic 
effects, such as reduced catalytic efficiency in the case of CHMO (Cheesman 2003) or 
inactivation in the case of HAPMO (Fraaije 2002). However, the wild type BVMOAf1 proved 
to be active and highly stereoselective. The observed mild mutation is also in line with the 
finding that some rhodococcal BVMOs do not have a fully conserved BVMO motif (Riebel 
2012). 
Intriguingly, there are no shared structural features among the identified substrates for this 
new enzyme. Therefore, we have named it BVMOAf1, according to its source organism. The 
low number of identified substrates for BVMOAf1 can be related to the fact that the activity 
screening assay has been designed based on the reported substrates for prokaryotic BVMOs. 
Nevertheless, the observed enantioselectivity was excellent in the bicyclic ketone oxidation 
as well as in the oxidation of thioanisole and benzyl ethyl sulfide. As control, conversion of 
cyclohexanone and phenylacetone were evaluated. Although these two ketones are accepted 
by many of the known BVMOs, no conversion was detected with BVMOAf1 and the 
substrates were fully recovered. These results showed that the enzyme is highly chemo-, 
regio-, and stereoselective, proving its interesting biocatalytic potential. The exploration of 
different substrates is currently underway in our laboratory. 
From the steady state kinetic analysis of BVMOAf1, it was found that the kcat values are rather 
modest (0.5 s-1) and independent of the type of substrate. This fact led us to propose that a 
predetermined reaction rate is expected for any compound capable of entering into the active 
site and react with the peroxyflavin. This assumption suggests that a kinetic event before or 
after oxygenation is limiting the rate of catalysis. To determine if the catalytic mechanism of 
this eukaryotic protein resembles that of the well-studied bacterial BVMOs, more detailed 
kinetic studies are necessary. Also, a very strict dependence of NADPH as cofactor was 
determined. This is a typical feature of all reported BVMOs so far, except for MekA from 
Pseudomonas veronii which seems to accept either NADH or NADPH as hydride donors 
(Völker et al. 2008). 
By testing different parameters such as temperature, pH and the addition of organic solvents, 
it was demonstrated that BVMOAf1 is a robust biocatalyst. Remarkably, the pre-incubation of 
the enzyme either in a broad pH range or in organic solvents resulted in no loss of activity. 
For some other enzymes it has been shown that the presence of organic solvents in the 
reaction media, even without longer incubation times, dramatically reduces the activity. For 
instance, the prototype BVMO, cyclohexanone monooxygenase, loses dramatically its 
activity when incubated with 5% of solvents. Its tolerance is very poor, since after 20 min 
incubation with 5% methanol the enzyme is completely inactivated (Secundo 2011). These 
features, in combination with the biocatalytic properties of BVMOAf1, make this enzyme a 
promising biocatalyst. 
BVMOAf1 has been extensively studied in this work, proving that this fungal enzyme has 
typical BVMO characteristics. However, there are some special features such as the substrate 
scope, the kinetic parameters and its high tolerance to harsh conditions that open new 
questions about eukaryotic BVMOs and encourage the work with other fungal enzymes 
belonging to this class. 
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